Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
KRONOX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kronox Lab Sciences reported Q1 FY26 revenue from operations of ₹2,428.65 lakhs, down about 3.6% from ₹2,519.26 lakhs in Q1 FY25. Despite the topline dip, profit after tax inched up to ₹627.87 lakhs (vs ₹615.02 lakhs, up ~2.1%), helped by lower total expenses and higher other income of ₹87.32 lakhs. Profit before tax rose modestly to ₹844.05 lakhs from ₹830.79 lakhs, with EPS at ₹1.70 versus ₹1.67 a year ago. The auditor (Mahesh Udhwani & Associates) issued an unqualified limited review report with no qualifications or emphasis of matter. For full-year FY25, revenue stood at ₹10,019.39 lakhs and PAT at ₹2,546.72 lakhs, providing context for the quarterly run-rate.
Marginal YoY revenue decline is a mild negative, but stable margins and steady PAT growth signal operational resilience for shareholders; near-term stock reaction likely to be neutral as the numbers are broadly in line with prior periods.